Dr. Sandeep Ramawat
Patient Education

Cancer Patient Guide & FAQs

Clear, evidence-based answers to the questions patients and families ask most often — and the myths that delay diagnosis and cost lives.

Myths & Facts

Clearing the myths
that cost lives.

Myth Biopsy spreads cancer

“Does a biopsy cause cancer to spread?”

This is one of the most common and most dangerous myths. A biopsy is essential to confirm the diagnosis and plan the right treatment, and the fear of it stops many people from getting diagnosed in time.

Myth Sugar feeds tumours

“Will cutting sugar cure my cancer?”

The relationship between diet and cancer is more nuanced than anything you will read online. Cutting sugar alone does not control or cure cancer. Evidence-based treatment does.

Myth Stage IV is always fatal

“Is Stage IV cancer always the end?”

Not all Stage IV cancers behave the same way. Some are treatable, and a few remain curable even at Stage IV. With newer advancements in therapies, many Stage IV cancer patients achieve long-term remissions, which is why an accurate diagnosis and expert guidance matter so much.

Myth Cancer is contagious

“Can cancer spread by touch or sharing meals?”

Cancer is not an infectious disease. It does not spread through touch, sharing food, or being close to someone. Patients and families need never fear ordinary contact.

True Screening saves lives

Early detection changes everything.

Screening for breast, cervical, lung and colon cancers can catch disease early, when it is most treatable. Knowing who should be screened and when is one of the most powerful tools we have.

True Family history matters

Some cancers run in families.

Hereditary cancers are real. Genetic testing, screening of asymptomatic family members, and risk-reducing decisions can protect entire families.

Questions

Questions patients ask most often

Cancer is generally described in stages that reflect how far it has spread. Stage IV means the cancer has spread to distant parts of the body. Accurate staging, usually with imaging and a biopsy, is essential before any treatment decision, because the stage shapes the entire plan.

A biopsy confirms exactly what type of cancer is present, which directly determines the correct treatment. Starting treatment on a PET-CT or CECT report alone, without tissue confirmation, risks treating the wrong disease. A biopsy does not cause cancer to spread.

Each has a distinct role. Surgery and radiation are often used for local control of the disease, while chemotherapy, immunotherapy and targeted therapy work throughout the body. The right combination depends on the cancer type, stage and overall health.

Chemotherapy can have short-term and long-term side effects, but most are anticipated and actively managed. Some are handled with simple precautions and medication; a few situations need closer medical attention. Fear of side effects should never be the reason to delay potentially life-saving treatment.

Immunotherapy helps the body's own immune system recognise and fight cancer, while targeted therapy acts on specific features of cancer cells. These represent some of the most significant advances in modern oncology, and their suitability depends on the individual cancer.

Some cancers carry a hereditary component. Genetic testing, guidance for asymptomatic family members, close surveillance, and risk-reducing options can meaningfully protect families.

Bring the biopsy and histopathology report, all imaging films and reports including PET-CT or CECT, recent blood tests, a list of current medicines, and a written summary of any treatment already received with dates. A family member or caregiver is also welcome.

Some complementary approaches can support wellbeing, but others interfere with chemotherapy, targeted therapy or immunotherapy. Always disclose everything you are taking, including herbal and ayurvedic preparations, so interactions can be checked before treatment starts.

Still have questions?

The clearest answers come from a consultation with your reports in hand. Call or message to arrange one.